- Report
- March 2024
- 198 Pages
Global
From €3283EUR$3,374USD£2,812GBP
€3648EUR$3,749USD£3,125GBP
- Report
- February 2024
- 187 Pages
Global
From €3503EUR$3,600USD£3,001GBP
- Report
- September 2019
- 40 Pages
Saudi Arabia
From €2525EUR$2,595USD£2,163GBP
- Report
- September 2019
- 40 Pages
Russia
From €2525EUR$2,595USD£2,163GBP
- Report
- September 2019
- 40 Pages
India
From €2525EUR$2,595USD£2,163GBP
- Report
- September 2019
- 40 Pages
Germany
From €2525EUR$2,595USD£2,163GBP
- Report
- September 2019
- 40 Pages
China
From €2525EUR$2,595USD£2,163GBP
- Report
- September 2019
- 40 Pages
Brazil
From €2525EUR$2,595USD£2,163GBP
- Report
- September 2019
- 80 Pages
Africa
From €3692EUR$3,795USD£3,163GBP
- Report
- September 2019
- 40 Pages
United States
From €2525EUR$2,595USD£2,163GBP
- Report
- September 2019
- 40 Pages
Ireland
From €2525EUR$2,595USD£2,163GBP
- Report
- September 2019
- 40 Pages
France
From €2525EUR$2,595USD£2,163GBP
Benzonatate is a cough and cold drug used to treat chest congestion and coughing. It is a non-narcotic, non-opioid medication that works by numbing the throat and lungs to reduce coughing. It is available in both capsule and liquid form and is typically taken three times a day. Benzonatate is often used in combination with other medications to treat cold and flu symptoms. Common side effects include drowsiness, dizziness, and nausea.
Benzonatate is a popular choice for treating cough and cold symptoms due to its effectiveness and lack of serious side effects. It is available over-the-counter and is relatively inexpensive compared to other cough and cold medications. It is also widely available in pharmacies and online retailers.
Some companies in the Benzonatate market include Pfizer, GlaxoSmithKline, Novartis, and Mylan. Show Less Read more